NASDAQ
Medexus Pharmaceuticals Inc. (MEDXF) has a fcf yield of 5.14% as of Monday, August 3, 2026. This represents a 78.68% decrease compared to its 12-month average of 24.10%. Free cash flow yield measures free cash flow per share as a percentage of the stock price, indicating cash return potential.
No price data available for this timeframe.